Monitoring the clinical practice of palliative sedation (PALSED) in patients with advanced cancer: an international, multicentre, non-experimental prospective observational study protocol - BMC Palliative Care

Australia News News

Monitoring the clinical practice of palliative sedation (PALSED) in patients with advanced cancer: an international, multicentre, non-experimental prospective observational study protocol - BMC Palliative Care
Australia Latest News,Australia Headlines
  • 📰 BioMedCentral
  • ⏱ Reading Time:
  • 51 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 71%

An article in BMCPalliatCare discusses PALSED: a study of similarities and differences in indication, practice and specific outcomes of palliative sedation in patients with advanced cancer with refractory symptoms across five European countries.

). When informed consent is gained, baseline information for all patients is collected for phase 1. Then study measurements are paused and participants are clinically followed by the health care team.Study flow phase 1 and phase 2.

]. The ECOG performance score is completed by one of the attending physicians or clinical researchers as a baseline measurement in this study.The Discomfort Scale-Dementia of Alzheimer Type is a validated instrument to assess discomfort in patients with severe dementia by observing patients’ behavior over 5 minutes of observation. Participating health care teams were trained online and at bedside how to use the DS-DAT tool.

This medication list contains information about: 1) Changes in dosages of sedative medication which is recorded in numbers and units ; 2) Changes in the sort of sedative medication used for palliative sedation which are recorded with the medication name; 3) Changes in the route of administration of sedative medication. All changes will be recorded with the accompanying date and time.

Differences between settings will be tested through a Chi-square test for categorical variables , Kruskal-Wallis test for ordinal variables, and ANOVA for continuous variables.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BioMedCentral /  🏆 22. in UK

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Eczema as a protective factor for brain cancer: a meta-analysis - BMC CancerEczema as a protective factor for brain cancer: a meta-analysis - BMC CancerBackground Brain cancer is one of the most aggressive cancer types owing to poor treatment effects. Epidemiological studies have demonstrated that allergies may increase the disease risk. Therefore, this study evaluated the association between eczema and the risk of various brain cancers. Methods We systematically searched the PubMed and Embase databases from their inception until June 23, 2022. Two reviewers independently reviewed and screened the articles, extracted data, assessed the study quality, and pooled the results. Stata software was used to generate pooled odds ratios and 95% confidence intervals (CIs). Results We included 20 studies comprising 5,117,222 patients that investigated the relationship between eczema and brain cancer. Eczema was significantly inversely associated with the risk of brain cancer (odds ratio [OR], 0.82; 95% CI, 0.77–0.87), glioma (OR, 0.53; 95% CI, 0.14–2.02), meningioma (OR, 0.74; 95% CI, 0.66–0.84), and acoustic neuroma (OR, 0.60; 95% CI, 0.41–0.88). Interesting, The strong correlation between eczema and the reduced risk of brain cancer was observed in people over 16 years old (OR, 0.79; 95% CI, 0.71–0.88), but not in those under 16 years old (OR, 0.94; 95% CI, 0.79–1.11). In addition, subgroup analyses found that eczema significantly decreased the glioma risk in Europeans (OR, 0.73; 95% CI, 0.65–0.82) but not Australians (OR, 0.53; 95% CI, 0.14–2.02) or Americans (OR, 1.01; 95% CI, 0.69–1.46). Conclusion Eczema may be considered as a potential protective factor of brain cancer in population aged over 16 years. However, this relationship requires verification using large-scale clinical data.
Read more »

New immunotherapy holds promise for ovarian cancerNew immunotherapy holds promise for ovarian cancerCAR T-cell therapy, a certain kind of cancer treatment in which the immune system's T cells are programmed to attack tumor cells, is effective in mice with ovarian cancer, according to a study published in The Journal for ImmunoTherapy of Cancer. The researchers, who work at Karolinska Institutet, hope that the discovery will pave the way for a clinical trial to see how effective the treatment is for women with the disease.
Read more »

'Patients are dying waiting': Inside the cardiac care crisis as doctors say lives 'put at risk''Patients are dying waiting': Inside the cardiac care crisis as doctors say lives 'put at risk'Patients’ lives are being put at risk because of “severe delays” in cardiac care, leading doctors have told theipaper 🔎 PatrickStrud reports:
Read more »

Rural areas in the U.S. have significantly less access to telehealth and cancer care servicesRural areas in the U.S. have significantly less access to telehealth and cancer care servicesRural areas in the U.S. have significantly less access to telehealth and cancer care services Cancer Coronavirus Disease COVID Telemedicine PLOSONE wakeforestmed UofSC UIowaCPH
Read more »

Feedback invited on Derby City Council's care plansFeedback invited on Derby City Council's care plansChanges are being proposed to early years care, occupational therapy and adult care.
Read more »

What is the effectiveness of different exercise modalities in reducing cancer-related fatigue in cancer patients undergoing chemotherapy?What is the effectiveness of different exercise modalities in reducing cancer-related fatigue in cancer patients undergoing chemotherapy?What is the effectiveness of different exercise modalities in reducing cancer-related fatigue in cancer patients undergoing chemotherapy? UV_EG exercise cancer oncology chemotherapy fatigue
Read more »



Render Time: 2025-03-11 03:21:18